Genomics and Applied Biology 2024, Vol.15, No.2, 99-106 http://bioscipublisher.com/index.php/gab 104 ensuring safety and sustainability (Okoli et al., 2021). These frameworks should include clear guidelines for the approval, monitoring, and commercialization of gene-edited aquatic species, with a focus on transparency and public engagement (Roy et al., 2022; Robinson et al., 2023). 6 Future Perspectives 6.1 Advances in CRISPR-Cas9 technology for aquaculture The CRISPR-Cas9 technology has revolutionized genetic engineering in aquaculture, offering precise and efficient genome editing capabilities. Recent advancements have focused on optimizing the CRISPR-Cas9 system for use in various fish species, including tilapia. For instance, detailed protocols have been developed for gene mutation in tilapia, covering target site selection, RNA transcription, and microinjection techniques, which facilitate the establishment of mutant lines (Li et al., 2020). Additionally, the technology has been applied to generate stable and heritable phenotypes, such as the solid-red germline in Nile tilapia, by targeting specific genes like slc45a2 (Segev-Hadar et al., 2021). These advancements not only enhance our understanding of fish genetics but also pave the way for broader applications in aquaculture, including improved growth rates and disease resistance (Gratacap et al., 2019; Gutási et al., 2023). 6.2 Integration of gene editing in commercial tilapia breeding programs The integration of CRISPR-Cas9 mediated gene editing into commercial tilapia breeding programs holds significant promise for the aquaculture industry. By enabling precise genetic modifications, CRISPR-Cas9 can expedite the breeding process, allowing for the rapid introduction of favorable traits such as enhanced growth and disease resistance (Gratacap et al., 2019). The high fecundity and external fertilization of tilapia make them ideal candidates for large-scale genome editing applications. However, challenges remain, including technical limitations and regulatory hurdles that need to be addressed to fully realize the potential of this technology in commercial settings (Segev-Hadar et al., 2021). Despite these challenges, the successful commercialization of CRISPR-edited fish, such as the red sea bream and the FLT-01 Nile tilapia, demonstrates the feasibility and potential benefits of integrating gene editing into breeding programs (Roy et al., 2022). 6.3 Prospects for broader applications in other aquatic species The success of CRISPR-Cas9 mediated gene editing in tilapia sets a precedent for its application in other aquatic species. The technology has already been applied to over 20 different aquaculture species, targeting traits such as growth, disease resistance, and reproduction (Roy et al., 2022). For example, genome editing has been used to create a new breed of red sea bream with increased skeletal muscle mass, demonstrating the potential for significant improvements in aquaculture productivity (Kishimoto et al., 2018). Furthermore, the development of gene editing protocols and optimization of Cas9 nuclear localization in fish cell lines will facilitate the application of CRISPR-Cas9 in a broader range of species (Villapando et al., 2020). As the technology continues to advance, it is expected to play a crucial role in addressing the challenges faced by the aquaculture industry, including disease outbreaks and environmental sustainability (Robinson et al., 2023). 7 Concluding Remarks The application of CRISPR-Cas9 in tilapia has demonstrated significant potential in enhancing growth rates and disease resistance. This gene-editing technology allows for precise modifications in the tilapia genome, leading to the development of desirable traits such as increased growth, improved disease resistance, and controlled reproduction. For instance, CRISPR-Cas9 has been successfully used to create stable and heritable phenotypes, such as the solid-red germline in Nile tilapia, which addresses market demands for specific fish traits. Additionally, the technology has enabled the efficient targeting of non-coding sequences, which play crucial roles in regulating various biological processes. Overall, CRISPR-Cas9 offers a powerful and versatile tool for genetic improvement in tilapia, promising to enhance productivity and sustainability in aquaculture. The long-term impacts of CRISPR-Cas9-mediated gene editing on the global aquaculture industry are profound. By enabling the rapid and precise development of desirable traits, CRISPR-Cas9 can significantly improve the efficiency and sustainability of fish farming. Enhanced growth rates and disease resistance in tilapia can lead to
RkJQdWJsaXNoZXIy MjQ4ODYzMg==